Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.063 AUD | +1.61% | -3.08% | +186.36% |
Apr. 30 | Nyrada's NYR-BI03 Being Studied For Potential in Traumatic Brain Injury | MT |
Apr. 18 | Transcript : Nyrada Inc., Q3 2024 Earnings Call, Apr 18, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
+186.36% | 7.39M | |
+39.06% | 723B | |
+34.19% | 595B | |
-2.76% | 369B | |
+19.89% | 332B | |
+2.19% | 282B | |
+16.98% | 244B | |
+9.54% | 208B | |
-4.91% | 205B | |
+1.11% | 168B |
- Stock Market
- Equities
- NYR Stock
- News Nyrada Inc.
- Nyrada Secures European Patent for Cholesterol Inhibitor Drug; Shares Rally 16%